Quinazolines for treating brain tumor
US6552027B2 · kind B2 · utility
24Cited by
9References
2Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 11, 2001 |
| Grant date | Apr 22, 2003 |
| Priority date | — |
| Expiry date | Jul 11, 2021 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D239/88
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel substituted quinozaline compounds and conjugates useful to inhibit the growth of brain tumor cells and to inhibit adhesion and migration of brain tumor cells. The compounds of the invention include 4-(3′-bromo-4′-hydroxy phenyl)-amino-6,7-dimethoxyquinazoline and this compound covalently bound to EGF.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.